Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Chamoto

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Cancer Research|December 3, 2004
Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunityYoshinori Suzuki, Daiko Wakita, Kenji Chamoto, et al.
Experimental Lung Research|August 22, 2012
Mechanostructural adaptations preceding postpneumonectomy lung growthBarry C Gibney, Jan P Houdek, Kenji Chamoto, et al.
International Immunopharmacology|December 15, 2010
Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium LSachi Tanaka, Shin-ichi Koizumi, Kazutaka Masuko, et al.
Cellular Immunology|May 30, 2009
Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cellsMegumi Goto, Masao Murakawa, Kumiko Kadoshima-Yamaoka, et al.
International Immunopharmacology|November 11, 2008
Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyteKumiko Kadoshima-Yamaoka, Masao Murakawa, Megumi Goto, et al.
Blood|March 26, 2005
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genesTakemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, et al.
Scientific Reports|April 1, 2016
CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cellsMunehide Nakatsugawa, Muhammed A Rahman, Yuki Yamashita, et al.
Immunology Letters|February 7, 2009
ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytesKumiko Kadoshima-Yamaoka, Masao Murakawa, Megumi Goto, et al.
Nature Communications|May 11, 2017
HLA-DP<sup>84Gly</sup> constitutively presents endogenous peptides generated by the class I antigen processing pathwayYuki Yamashita, Mark Anczurowski, Munehide Nakatsugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRsKenji Chamoto, Tingxi Guo, Stephen W Scally, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Cancer Research|December 3, 2004
Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunityYoshinori Suzuki, Daiko Wakita, Kenji Chamoto, et al.
Experimental Lung Research|August 22, 2012
Mechanostructural adaptations preceding postpneumonectomy lung growthBarry C Gibney, Jan P Houdek, Kenji Chamoto, et al.
International Immunopharmacology|December 15, 2010
Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium LSachi Tanaka, Shin-ichi Koizumi, Kazutaka Masuko, et al.
Cellular Immunology|May 30, 2009
Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cellsMegumi Goto, Masao Murakawa, Kumiko Kadoshima-Yamaoka, et al.
International Immunopharmacology|November 11, 2008
Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyteKumiko Kadoshima-Yamaoka, Masao Murakawa, Megumi Goto, et al.
Blood|March 26, 2005
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genesTakemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, et al.
Scientific Reports|April 1, 2016
CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cellsMunehide Nakatsugawa, Muhammed A Rahman, Yuki Yamashita, et al.
Immunology Letters|February 7, 2009
ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytesKumiko Kadoshima-Yamaoka, Masao Murakawa, Megumi Goto, et al.
Nature Communications|May 11, 2017
HLA-DP<sup>84Gly</sup> constitutively presents endogenous peptides generated by the class I antigen processing pathwayYuki Yamashita, Mark Anczurowski, Munehide Nakatsugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRsKenji Chamoto, Tingxi Guo, Stephen W Scally, et al.
Pageof 11